CoChat
Sign Up
Cited by 139

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Increased risk of leukemia among sickle cell disease patients in California

Brunson, Ann, Keegan, Theresa H. M., Bang, Heejung, Mahajan, Anjlee, Paulukonis, Susan, Wun, Ted·2017·Blood
DOI 10.1182/blood-2017-05-783233
Open this paper in CoChat — free account

Abstract

To the editor: Due to improvements in treatment and care, the life expectancy of patients with sickle cell disease (SCD) has improved over the last 50 years[1][1] such that many patients now survive to an age where they are at an increased risk for cancer.[2][2] Previously reported small case

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2017-05-783233

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 3 references

Research works printed but not linked: 22

  1. Paulukonis, 2016, Defining sickle cell disease mortality using a population-based surveillance system, 2004 through 2008, Public Health Rep, 131, 367, 10.1177/003335491613100221 · DOI
  2. Chen, 2005, Chronic myelogenous leukemia in sickle cell anemia, Arch Pathol Lab Med, 129, 423, 10.5858/2005-129-423-CMLISC · DOI
  3. Moschovi, 2001, Hodgkin’s disease in a child with sickle cell disease treated with hydroxyurea [published correction appears in Pediatr Hematol Oncol. 2007;24(8):651], Pediatr Hematol Oncol, 18, 371, 10.1080/088800101316921985 · DOI
  4. Stricker, 1986, Hematologic malignancy in sickle cell disease: report of four cases and review of the literature, Am J Hematol, 21, 223, 10.1002/ajh.2830210212 · DOI
  5. Wilson, 2000, Acute leukemia in a patient with sickle-cell anemia treated with hydroxyurea, Ann Intern Med, 133, 925, 10.7326/0003-4819-133-11-200012050-00029 · DOI
  6. Schultz, 2003, Malignancy in patients with sickle cell disease, Am J Hematol, 74, 249, 10.1002/ajh.10427 · DOI
  7. Seminog, 2016, Risk of individual malignant neoplasms in patients with sickle cell disease: English National Record Linkage Study, J R Soc Med, 109, 303, 10.1177/0141076816651037 · DOI · Paper page
  8. Brunson, 2017, Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality, Br J Haematol, 178, 319, 10.1111/bjh.14655 · DOI
  9. Adesina, 2017, Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California, Blood Adv, 1, 1287, 10.1182/bloodadvances.2017005256 · DOI
  10. Paulukonis, 2014, Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH), Pediatr Blood Cancer, 61, 2271, 10.1002/pbc.25208 · DOI
  11. Eisenbrown, 2015, The accuracy of using ICD-9-CM codes to determine genotype and fever status of patients with sickle cell disease, Pediatr Blood Cancer, 62, 924, 10.1002/pbc.25432 · DOI
  12. California Cancer Registry, 2015, California Cancer Reporting System Standards: Abstracting and Coding Procedures for Hospitals
  13. Breslow, 1987, Statistical methods in cancer research. Volume II--The design and analysis of cohort studies, IARC Sci Publ, 1
  14. Brandow, 2010, Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities, Expert Rev Hematol, 3, 255, 10.1586/ehm.10.22 · DOI
  15. Lanzkron, 2008, Systematic review: hydroxyurea for the treatment of adults with sickle cell disease, Ann Intern Med, 148, 939, 10.7326/0003-4819-148-12-200806170-00221 · DOI
  16. Platt, 2000, Sickle cell anemia as an inflammatory disease, J Clin Invest, 106, 337, 10.1172/JCI10726 · DOI
  17. Kundu, 2012, Emerging avenues linking inflammation and cancer, Free Radic Biol Med, 52, 2013, 10.1016/j.freeradbiomed.2012.02.035 · DOI
  18. Crusz, 2015, Inflammation and cancer: advances and new agents, Nat Rev Clin Oncol, 12, 584, 10.1038/nrclinonc.2015.105 · DOI · Paper page
  19. Aggarwal, 2006, Inflammation and cancer: how hot is the link?, Biochem Pharmacol, 72, 1605, 10.1016/j.bcp.2006.06.029 · DOI · Paper page
  20. Chung, 2015, Thalassaemia and risk of cancer: a population-based cohort study, J Epidemiol Community Health, 69, 1066, 10.1136/jech-2014-205075 · DOI
  21. Zacharski, 2008, Decreased cancer risk after iron reduction in patients with peripheral arterial disease: results from a randomized trial, J Natl Cancer Inst, 100, 996, 10.1093/jnci/djn209 · DOI · Paper page
  22. Terman, 2013, Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response, PLoS One, 8, e52543, 10.1371/journal.pone.0052543 · DOI

Cited by

Metadata

Authors
Brunson, A., Keegan, T. H. M., Bang, H., Mahajan, A., Paulukonis, S., & Wun, T.
Venue
Blood
Publisher
American Society of Hematology
Published
2017-09-28
Volume
130
Issue
13
Pages
1597-1599
ISSN
  • 0006-4971
  • 1528-0020
DOI
10.1182/blood-2017-05-783233
Cited by
139
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review